Concepedia

Kay Meshaw

KM

Statistics

Publications

3

Citations

52

H-Index

3

Active since

2004

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Kay Meshaw is an author at Vertex Pharmaceuticals (United States) specializing in cancer research, tumor biology, and medicine.

Top concepts

MedicineTumor BiologyCancer ResearchOncologyCell BiologyCancer BiologyRadiation OncologyTumor MicroenvironmentHealthPathology

Publications per year

2004–2015

3

Publications

3

Abstract 4693: The selective ERK inhibitor BVD-523 is active in models of MAPK pathway-dependent cancers, including those with intrinsic and acquired drug resistance

Ursula A. Germann, Brinley F. Furey, Jeff Roix et al. · Cancer Research · 2015 · 21 citations

Chemoprevention Strategy, Cancer Biology, Tumor Biology +18

Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice

Patricia Rafferty, Devon Egenolf, Kerry Brosnan et al. · Journal of Immunotoxicology · 2012 · 16 citations · Full text

Squamous Cell Carcinoma, Immunology, Immunoediting +19

Identification of cell surface and secreted proteins essential for tumor cell survival using a genetic suppressor element screen

Marina S. Gelman, X Katherine Ye, Robert Stull et al. · Oncogene · 2004 · 15 citations

Tumor Cell Survival, Medicine, Cell Surface +9

1–3 of 3